---
title: "SUMMIT THERAPEUTICS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/aeec3fc4-8728-54fd-bd16-34028c94213a
json: https://whiteintel.dev/api/public/dossier/aeec3fc4-8728-54fd-bd16-34028c94213a
identifier: oo:GB-COH-05197494
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SUMMIT THERAPEUTICS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-05197494`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/aeec3fc4-8728-54fd-bd16-34028c94213a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/aeec3fc4-8728-54fd-bd16-34028c94213a  

## Cross-source identity

The same real-world entity, resolved across sources:

- **SUMMIT THERAPEUTICS PLC** — GLEIF · `lei:213800NRW8AOMYMTBD89` — https://whiteintel.dev/entity/d3fdd90b-af3e-5906-8321-ffe056ef8770

## Ownership & control

### Owners / controllers

- **Summit Therapeutics Inc.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/e1cbe79e-1c27-4517-a4e5-697ce7d65a7f

### Holdings / subsidiaries

- **SUMMIT (OXFORD) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/91d16ec6-1cd4-5400-a396-e4468de746e1
- **DISCUVA LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/7e0fd61b-48d1-5ac2-afb6-6f71b3a26979
- **DISCUVA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/7e0fd61b-48d1-5ac2-afb6-6f71b3a26979
- **SUMMIT (OXFORD) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/91d16ec6-1cd4-5400-a396-e4468de746e1

### UBO chain (walk to the ultimate owner)

A **1-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `05197494`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2004-08-04
- **Registered office:** 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire, OX14 4SB, United Kingdom
- **SIC:** 72110

### Officers

- ANAND, Bhaskar — director · American · appointed 2024-04-17
- DUGGAN, Robert William — director · American · appointed 2019-12-24
- SONI, Manmeet Singh — director · American · appointed 2023-12-06
- BENNING PRINCE, Sharon Jeen — secretary · British · appointed 2008-07-31 · resigned 2008-11-17
- INNOCENT, Kenneth Ronald — secretary · British · appointed 2009-04-03 · resigned 2010-01-20
- MILLINGTON, Darren Michael — secretary · British · appointed 2005-06-06 · resigned 2008-07-31
- MONTGOMERY, John Alexander — secretary · British · appointed 2004-09-24 · resigned 2005-06-06
- O'NEILL, Hugh Feargal — secretary · appointed 2020-06-30 · resigned 2021-06-08
- SPENCER, Raymond John — secretary · British · appointed 2010-01-20 · resigned 2014-09-03
- STRANGE, Melissa Claire — secretary · appointed 2014-09-03 · resigned 2020-06-30
- WEIR, Anthony — secretary · British · appointed 2008-11-17 · resigned 2009-03-23
- SWIFT INCORPORATIONS LIMITED — corporate nominee secretary · appointed 2004-08-04 · resigned 2004-09-24
- ANDREWS, Valerie — director · American · appointed 2014-09-18 · resigned 2019-10-11
- ARMSTRONG, Frank, Dr — director · British · appointed 2012-11-21 · resigned 2019-12-24
- DAVIES, Stephen Graham, Professor — director · British · appointed 2013-11-22 · resigned 2018-09-20
- DAVIES, Stephen Graham, Professor — director · British · appointed 2004-09-24 · resigned 2013-02-28
- DHINGRA, Ankur — director · American · appointed 2022-08-18 · resigned 2024-04-02
- EDWARDS, Glyn Owain — director · British · appointed 2012-04-04 · resigned 2020-06-18
- ELLIOTT, George Reginald — director · British · appointed 2007-04-19 · resigned 2012-11-21
- ERDTMANN, Rainer — director · American · appointed 2020-04-17 · resigned 2020-11-11

### Beneficial owners (Persons with Significant Control)

- [Summit Therapeutics Inc.](https://whiteintel.dev/entity/e1cbe79e-1c27-4517-a4e5-697ce7d65a7f) — 75–100% shares · corporate PSC · United States — since 2020-09-18

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/05197494
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/05197494

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **SUMMIT THERAPEUTICS LIMITED** — https://whiteintel.dev/entity/aeec3fc4-8728-54fd-bd16-34028c94213a · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SUMMIT THERAPEUTICS LIMITED**. Human view: https://whiteintel.dev/entity/aeec3fc4-8728-54fd-bd16-34028c94213a · Structured JSON: https://whiteintel.dev/api/public/dossier/aeec3fc4-8728-54fd-bd16-34028c94213a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._